Search
for
Sort by
Research 751–780 of 1000+
- Advances in Understanding Hair Growth
- Changes of androgens levels in menopausal women
- Zinc: A complementary factor in the treatment of chronic hepatitis C? (Review)
- Decreased lipin 1β expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome
- Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase
- A novel and safe small molecule enhances hair follicle regeneration by facilitating metabolic reprogramming
- Promotion Effect of Apo-9′-fucoxanthinone from <i>Sargassum muticum</i> on Hair Growth <i>via</i> the Activation of Wnt/β-Catenin and VEGF-R2
- In vitro biomimetic platforms featuring a perfusion system and 3D spheroid culture promote the construction of tissue-engineered corneal endothelial layers
- Diseases on Hair Follicles Leading to Hair Loss Part I: Nonscarring Alopecias
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Alopecia Areata, Primary Sclerosing Cholangitis, and Ulcerative Colitis: Autoimmunity and Apoptosis as Common Links?
- Androgenetic Alopecia
- Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss
- Frontal fibrosing alopecia: A new autoimmune entity?
- Female-patterned alopecia in teenage brothers with unusual histologic features
- Disorders of hair
- Hair loss and its management in children
- Male Pattern Baldness
- Management of autoimmune associated alopecia areata
- Telogen Effluvium
- Clinical use of 5α-reductase inhibitors
- Debatable Topics in PCOS Patients
- Causality of Aging Hallmarks
- The demographic and clinical profile of patients with alopecia areata in Syria: A study letter
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- Caring for women with polycystic ovary syndrome
- Melanocytes and Vitiligo (and Hair Graying)
- ALOPECIA AREATA-A CLINICAL ANALYSIS
- Management of autoimmune associated alopecia areata
- Comparative study of the efficacy and safety of topical minoxidil 2% versus topical bimatoprost 0.01% versus topical bimatoprost 0.03% in treatment of eyebrow hypotrichosis: a randomized controlled trial